DIEBOLD NIXDORF, Inc DBD
NYSE · XNYS · stock · Calculating & Accounting Machines (No Electronic Computers)
Chart by TradingView
7/9
Piotroski F — financial health
1.63
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $3.8B | $94.6M | $961.2M | — | $1.1B |
| 2024 | $3.8B | -$16.5M | $920.0M | — | $938.2M |
| 2022 | $3.5B | -$581.4M | $757.3M | — | -$1.4B |
| 2021 | $3.9B | -$78.8M | $1.0B | — | -$837.0M |
| 2020 | $3.9B | -$269.1M | $1.0B | — | -$831.7M |
| 2019 | $4.4B | -$341.3M | $1.1B | — | -$506.3M |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.63 (grey)
- Working capital / assets 0.108
- Retained earnings / assets 0.024
- EBIT / assets 0.063
- Equity / liabilities 0.402
Source: SEC EDGAR filings · CIK 0000028823 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.